Product NDC: | 50383-810 |
Proprietary Name: | Acyclovir |
Non Proprietary Name: | Acyclovir |
Active Ingredient(s): | 200 mg/5mL & nbsp; Acyclovir |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50383-810 |
Labeler Name: | Hi-Tech Pharmacal Co., Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077026 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050607 |
Package NDC: | 50383-810-16 |
Package Description: | 473 mL in 1 BOTTLE (50383-810-16) |
NDC Code | 50383-810-16 |
Proprietary Name | Acyclovir |
Package Description | 473 mL in 1 BOTTLE (50383-810-16) |
Product NDC | 50383-810 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Acyclovir |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20050607 |
Marketing Category Name | ANDA |
Labeler Name | Hi-Tech Pharmacal Co., Inc. |
Substance Name | ACYCLOVIR |
Strength Number | 200 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |